Asset Publisher

Identification of key gene for improvement of multiple sclerosis treatments

Identification of key gene for improvement of multiple sclerosis treatments

Karl Carlström and Fredirk Piehl. Photo: Stefan Zimmermann

 

CMM researcher Karl Carlström and colleagues have found that the Gsta4 gene functions as a protector of oligodendrocytes, the cell type that is destroyed by the immune system in patients with multiple sclerosis (MS). Among the coauthors of the paper, Keying Zhu, Ewoud Ewing, Robert A. Harris, Maja Jagodic and Fredrik Piehl (last author) are also researchers at CMM.

The study, which was recently published in Nature Communications, shows that Gsta4 mediates the maturation process in oligodendrocytes in rats and is needed for the effect of some known and future MS drugs.

Oligodendrocytes are found in the central nervous system and produce lipid-rich myelin sheets surrounding and insulating nerve axons. Immune attacks on the myelin, destruction of oligodendrocytes and the nerves, eventually leads to disability in individuals affected by MS.

Through experiments with a rat model of MS the researchers found that high levels of Gsta4 seem to speed up the maturation, promote repair and prevent apoptotic death signaling in damaged oligodendrocytes.

During the progressive stage of MS, oligodendrocytes and neurons in the brain die without re-forming. The experimental results presented in this paper can shed light on the mechanisms behind disease progression, but also on the mechanism of action of the drugs in use, or soon to be used, for MS.

 

A more detailed summary of the study is found on the KI webpage 

 

Publication:

Gsta4 controls apoptosis of differentiating adult oligodendrocytes during homeostasis and remyelination via the mitochondria-associated Fas-Casp8-Bid-axis.” Karl E Carlström, Keying Zhu, Ewoud Ewing, Inge E Krabbendam, Robert A Harris, Ana Mendanha Falcão, Maja Jagodic, Gonçalo Castelo-Branco and Fredrik Piehl. Nature Communications, online 13 August 2020, doi 10.1038/s41467-020-17871-5.

NEWS

Ning Xu Landén 2020 year’s winner of the LEO Foundation Award

Ning Xu Landén 2020 year’s winner of the LEO Foundation Award Associate Professor Ning Xu Landén, Group Leader at CMM is the winner of this year’s LEO Foundation Award in Region EMEA...

Nils Landegren receives ERC Starting Grant for studying sex differences in the human immune system

Nils Landegren receives ERC Starting Grant for studying sex differences in the human immune system Photo: Hans Ericksson, SSMF Nils Landegren , Researcher at CMM, has been awarded...

Verification project of SARS-CoV-2 antibody tests receives funding from Swelife

Verification project of SARS-CoV-2 antibody tests receives funding from Swelife Photo: Mattias Bronge, Karolinska Institutet A validation project of new SARS-CoV-2 antibody tests,...

Grant to Qiaolin Deng for the single-cell technology core at CMM

Grant to Qiaolin Deng for the single-cell technology core at CMM Qiaolin Deng, private photo We congratulate Associate Professor and CMM Team Leader Qiaolin Deng who received a SFO...

Identification of key gene for improvement of multiple sclerosis treatments

Identification of key gene for improvement of multiple sclerosis treatments Karl Carlström and Fredirk Piehl. Photo: Stefan Zimmermann   CMM researcher Karl Carlström and...

Sweden’s innovation agency Vinnova extends the funding of Genomic Medicine Sweden with additional SEK 36 million

Sweden’s innovation agency Vinnova extends the funding of Genomic Medicine Sweden with additional SEK 36 million Sweden’s innovation agency Vinnova extends the funding of the national...

The Swedish Heart-Lung Foundation major grant 2020 goes to Marie Wahren-Herlenius

The Swedish Heart-Lung Foundation major grant 2020 goes to Marie Wahren-Herlenius Professor Marie Wahren-Herlenius, Group Leader at CMM, has received the biggest yearly grant in Sweden...

Simple blood test may help predict MS progression, study finds

Simple blood test may help predict MS progression, study finds Photo: Ali Manouchehrinia   A study led by the CMM researchers Ali Manouchehrinia (first...

Experimental study finds new substances with higher specificity and therapeutic potential in multiple sclerosis

Experimental study finds new substances with higher specificity and therapeutic potential in multiple sclerosis   Karl Carlström, photo Stefan Zimmerman   Karl...

Early exposure to cannabis boosts young brains' sensitivity to cocaine, rodent study shows

Early exposure to cannabis boosts young brains' sensitivity to cocaine, rodent study shows A study made by Philippe Melas from Karolinska Institutet together with colleagues at Columbia...